The Globe and Mail
🏢 Globe and Mail Inc. (Woodbridge)
📍 AB
Jul 10, 2026
· 6 min read
AI Analyzed
○ Unverifiable
View full audit trail →
‘Patients who are being denied access to unapproved cancer treatments should take lessons from AIDS activists and their doctors.’ Letters to the editor for July 10
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · RIGHT
ML v2 (DistilBERT)
-0.250 · LEFT
Ensemble
-0.125 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.008
6,785 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
🔗 Cross-Watch
Named in this story — also tracked across the Watch Series.
Pierre Poilievre person
Civic
Article Excerpt
LETTERS
Letters to the editor, July 10: ‘Patients who are being denied access to unapproved cancer treatments should take lessons from AIDS activists and their doctors’
CONTRIBUTED TO THE GLOBE AND MAIL
PUBLISHED 46 MINUTES AGO
Open this photo in gallery:
A new drug, daraxonrasib, doubles survival time for people with pancreatic cancer.
DANIELLE VILLASANA/REUTERS
COMMENTS
SHARE
SAVE FOR LATER
Life and death
Re “Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patients” (July 8): Oncologists and patients who are being denied access to unapproved cance…
Read full article at The Globe and Mail ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1
Jul 10, 2026